Vikas Sharma

Biotechnology Patent Guidelines 2013, paragraphs 6 to 9: prior art search, novelty of product-by-process, sequence and composition claims, inventive step, and industrial application including gene fragments4 Oct 2026 Biotechnology Patent Guidelines 2013, paragraphs 1 to 5: scope, a brief history of biotechnology patenting in India, the provisions covered and the kinds of claims met in biotechnology applications4 Oct 2026 Pharmaceutical Patent Guidelines 2014, paragraph 12: unity of invention - a priori and a posteriori findings, different categories of claims, Markush claims, and intermediates and final products4 Oct 2026 Pharmaceutical Patent Guidelines 2014, paragraph 11: sufficiency of description, clarity and support of the claims - Markush groups, functional claims and the illustrative examples4 Oct 2026 Pharmaceutical Patent Guidelines 2014, paragraphs 9 and 10: industrial applicability, and section 3(b), (c), (e), (i), (j) and (p) - synergy in compositions, methods of treatment, and plant and traditional-knowledge claims4 Oct 2026 Pharmaceutical Patent Guidelines 2014, paragraph 10: section 3(d) - new forms of known substances, what "efficacy" means for a medicine, the data the examiner expects, and the illustrative examples4 Oct 2026 Pharmaceutical Patent Guidelines 2014, paragraph 8: assessing inventive step - the person skilled in the art, reasonable expectation of success, the objective method and the illustrative examples4 Oct 2026 Pharmaceutical Patent Guidelines 2014, paragraph 7: assessing novelty - prior disclosure, generic and specific disclosures, combinations and compositions, and product-by-process claims4 Oct 2026 Pharmaceutical Patent Guidelines 2014, paragraphs 1 to 6: scope, the provisions covered, the kinds of claims met in pharmaceutical applications including Markush claims, the prior art search and what counts as an invention4 Oct 2026 TK and Biological Material Guidelines 2012: novelty and inventive step for traditional knowledge inventions - the six guiding principles and their illustrations4 Oct 2026 TK and Biological Material Guidelines 2012: how the Patent Office screens and classifies traditional knowledge applications, who examines them, the Form 1 declaration on biological material and the National Biodiversity Authority permission4 Oct 2026 Guidelines for the Use of AI in Patent Examination, Annexure I: the illustrative examples - classification, search terms, claim-feature extraction, translation, drafting, citations, novelty and inventive step mapping, clarity and sufficiency checks4 Oct 2026